当前位置:首页 - 行情中心 - 欧林生物(688319) - 财务分析 - 现金流量表

欧林生物

(688319)

  

流通市值:92.88亿  总市值:93.00亿
流通股本:4.05亿   总股本:4.06亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金237,674,014.5106,818,944.63512,250,408.16340,836,601.11
  收到其他与经营活动有关的现金11,620,766.674,879,458.4123,490,531.7212,334,317.73
  经营活动现金流入小计249,294,781.17111,698,403.04535,740,939.88353,170,918.84
  购买商品、接受劳务支付的现金21,283,596.5911,662,988.1665,085,042.3256,616,159.86
  支付给职工以及为职工支付的现金57,240,194.4835,291,434.695,916,970.1573,810,219.74
  支付的各项税费21,604,554.538,592,992.8725,588,016.1217,647,070.46
  支付其他与经营活动有关的现金168,905,116.0979,654,862.83358,882,121.69266,825,866.66
  经营活动现金流出小计269,033,461.69135,202,278.46545,472,150.28414,899,316.72
  经营活动产生的现金流量净额-19,738,680.52-23,503,875.42-9,731,210.4-61,728,397.88
二、投资活动产生的现金流量:
  收回投资收到的现金35,000,00015,000,000219,000,100137,000,100
  取得投资收益收到的现金150,511.6470,592.05855,559.79500,625.69
  处置固定资产、无形资产和其他长期资产收回的现金净额27,730.8-29,417.47-
  投资活动现金流入小计35,178,242.4415,070,592.05219,885,077.26137,500,725.69
  购建固定资产、无形资产和其他长期资产支付的现金39,268,914.0818,388,849.27207,319,279.08147,386,408.01
  投资支付的现金35,100,00020,100,000236,500,000214,000,000
  投资活动现金流出小计74,368,914.0838,488,849.27443,819,279.08361,386,408.01
  投资活动产生的现金流量净额-39,190,671.64-23,418,257.22-223,934,201.82-223,885,682.32
三、筹资活动产生的现金流量:
  取得借款收到的现金95,000,00045,000,000206,823,147201,823,147
  筹资活动现金流入小计95,000,00045,000,000206,823,147201,823,147
  偿还债务支付的现金68,580,00027,100,00078,850,00057,630,000
  分配股利、利润或偿付利息支付的现金7,329,320.793,661,216.2429,677,215.9525,808,837.01
  支付其他与筹资活动有关的现金--2,388,5612,388,561
  筹资活动现金流出小计75,909,320.7930,761,216.24110,915,776.9585,827,398.01
  筹资活动产生的现金流量净额19,090,679.2114,238,783.7695,907,370.05115,995,748.99
五、现金及现金等价物净增加额-39,838,672.95-32,683,348.88-137,758,042.17-169,618,331.21
  加:期初现金及现金等价物余额217,776,831.01217,776,831.01355,534,873.18355,534,873.18
  期末现金及现金等价物余额177,938,158.06185,093,482.13217,776,831.01185,916,541.97
补充资料:
  净利润13,229,790.42-15,720,687.32-
  资产减值准备-491,601.37--2,936,350.79-
  固定资产和投资性房地产折旧15,774,126.48-27,659,900.76-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧15,774,126.48-27,659,900.76-
  无形资产摊销628,784.7-1,117,975.94-
  长期待摊费用摊销2,065,184.07-3,525,195.69-
  处置固定资产、无形资产和其他长期资产的损失-8,707.05-30,988.3-
  固定资产报废损失14,669.24---
  财务费用7,455,488.08-14,458,884.08-
  投资损失-150,511.64--855,559.79-
  递延所得税---4,388,692.61-
  其中:递延所得税资产减少---4,132,270.7-
    递延所得税负债增加---256,421.91-
  存货的减少9,644,591.23--13,565,825.06-
  经营性应收项目的减少-104,984,738.88--83,626,940.93-
  经营性应付项目的增加3,394,391.26-19,057,173.78-
  现金的期末余额177,938,158.06-217,776,831.01-
  减:现金的期初余额217,776,831.01-355,534,873.18-
  现金及现金等价物的净增加额-39,838,672.95--137,758,042.17-
公告日期2025-08-292025-04-262025-03-292024-10-30
审计意见(境内)标准无保留意见
TOP↑